- Summary
- Stats & Ratios
- Income Statement
- Balance Sheet
- Cash Flow
- Opinions
China Shenghuo Pharmaceutical Holdings, Inc
(AMEX:KUN)- View:
- Quarterly Data
- Annual Data
- Note: All numbers in thousands
| Sep 30, 2008 | Jun 30, 2008 | Mar 31, 2008 | Dec 31, 2007 | |
|---|---|---|---|---|
| Operating revenue | ||||
| Total Revenue | 7,281 | 7,281 | 5,486 | 5,089 |
| Operating Revenue | 7,281 | 7,281 | 5,486 | 5,089 |
| Adjustments To Revenue | — | — | — | — |
| Cost Of Sales | 1,974 | 1,554 | 1,900 | 1,104 |
| Cost Of Sales With Depreciation | 1,974 | 1,974 | 2,099 | 1,277 |
| Gross Operating Profit | 5,308 | 5,727 | 3,587 | 3,985 |
| Operating Expenses | ||||
| Research And Development Expenses | 66 | 66 | 119 | 262 |
| Selling General And Administrative Expenses | 4,809 | 4,809 | 3,213 | 3,893 |
| Advertising Expenses | — | — | — | — |
| Operating Income Before Depreciation | 432 | 852 | 255 | -169 |
| Operating Income | 432 | 432 | 55 | -342 |
| Depreciation | — | 420 | 200 | 173 |
| Depreciation Unreconciled | — | — | — | — |
| Amortization | — | — | — | — |
| Amortization Of Intangibles | — | — | — | — |
| Operating Income After Depreciation | 432 | 432 | 55 | -342 |
| Non Operating Expenses | ||||
| Interest Expense | 272 | 272 | 256 | 281 |
| Pre Tax Income | 166 | 166 | -8 | -327 |
| Income Taxes | 4 | 4 | 353 | -756 |
| Minority Interest | 8 | 8 | -22 | 71 |
| Income Before Income Taxes | 166 | 166 | -8 | -327 |
| Net Income From Continuing Operations | 154 | 154 | -338 | 358 |
| Net Income From Discontinued Operations | — | — | — | — |
| Net Income From Total Operations | 154 | 154 | -338 | 358 |
| Non Recurring Events | ||||
| Extraordinary Income Losses | — | — | — | — |
| Income From Cummulated Effect Of Accounting Changes | — | — | — | -449 |
| Income From Tax Loss Carryforward | — | — | — | — |
| Other Gains And Losses | — | — | — | — |
| Total Net Income | 154 | 154 | -338 | -91 |
| Normalized Income | 154 | 154 | -601 | 358 |
| NetIncome Available For Common | 154 | 154 | -338 | 358 |
| Preferred Dividends | — | — | — | — |
| Excise Taxes | — | — | — | — |